The National Agency for Food and Drug Administration and Control (NAFDAC) has announced the withdrawal, suspension, or cancellation of 101 pharmaceutical products from circulation in Nigeria.

The agency announced the decision in a statement released on the its X handle on Tuesday saying the affected products “are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria.”

According to the agency, the action followed requests by market authorisation holders to withdraw some products, while others were suspended or cancelled by the agency.

It explained that the list which covers items across medicines and health products from antimalarials (various artemether/lumefantrine formulations) and cardiovascular drugs (valsartan products) to insulin/growth-hormone injectables (Norditropin), diabetes medicines (Januvia/Janumet), inhalers and eye drops can be accessed on the NAFDAC website.

Among the delisted drugs are Flagyl suspension and tablet which is widely used to treat diarrhoea; Artemether/Lumefantrine, an antimalarial; Penicillin G Sodium Sandoz powder, prescribed for bacterial infections; diabetes medicines (Januvia/Janumet), inhalers and eye drops.

“This is to inform the General Public that the following products are approved for withdrawal, suspension and cancellation by NAFDAC,” the statement reads.

“They are therefore no longer permitted for manufacture, importation, exportation, distribution, advertisement, sale and use within Nigeria.

“Please note that the certificate of registration of a product is said to be withdrawn when the use of the Certificate of Registration of that product is discontinued upon request of the Market Authorization Holder.”

List of Withdrawn, Suspended and Cancelled products as approved by NAFDAC

S/N	Product name	Dosage form	NAFDAC Number	Active Ingredient	Market Authorization Holder	Application Purpose
1	Abacavir Sulfate/Lamivudine Dispersible Tablets 60mg/30mg	Tablets	C4-1180	Abacavir sulfate and Lamivudine	Healthline Limited	Withdrawn Voluntarily by Market Authorization Holder
2	Amaryl M Tablets	Tablets	A4-2619	Glimepiride + Metformin Hydrochloride	Sanofi Aventis Nigeria Ltd	Withdrawn Voluntarily by Market Authorization Holder
3	Amaryl M SR Tablets	Tablets	A4-7296	Glimepiride + Metformin Hydrochloride	Sanofi Aventis Nigeria Ltd	Withdrawn Voluntarily by Market Authorization Holder
4	Aprovasc 150mg/5mg tablets	Tablets	B4-2687	Amlodipine Besylate + ? (Aprovasc)	Sanofi Aventis Nigeria Ltd	Withdrawn Voluntarily by Market Authorization Holder
5	Artemether/Lumefantrine 40mg/240mg Tablets	Tablets	B4-5745	Artemether/Lumefantrine 40mg/240mg	Healthline Limited	Withdrawn Voluntarily by Market Authorization Holder
6	ASAQ (Artesunate amodiaquine Winthrop) 100mg/270mg Tablets	Tablets	A4-3357	Artesunate Amodiaquine Winthrop 100mg/270mg	Sanofi Aventis Nigeria Ltd	Withdrawn Voluntarily by Market Authorization Holder
7	ASAQ (Artesunate amodiaquine Winthrop) 25mg/67.5mg Tablets	Tablets	A4-3406	Artesunate Amodiaquine Winthrop 25mg/67.5mg	Sanofi Aventis Nigeria Ltd	Withdrawn Voluntarily by Market Authorization Holder
8	ASAQ (Artesunate amodiaquine Winthrop) 50mg/135mg Tablets	Tablets	A4-3405	Artesunate Amodiaquine Winthrop 50mg/135mg	Sanofi Aventis Nigeria Ltd	Withdrawn Voluntarily by Market Authorization Holder
9	Betopic Eye drop	Eye Drop	04 2404	Betaxolol Hydrochloride	Novartis Nigeria Limited	Withdrawn Voluntarily by Market Authorization Holder
10	Coaprovel 300mg/25mg Tablets	Tablets	B4-2317	Hydrochlorothiazide + Irbesartan	Sanofi Aventis Nigeria Ltd	Withdrawn Voluntarily by Market Authorization Holder